-
公开(公告)号:ZA895176B
公开(公告)日:1990-03-28
申请号:ZA895176
申请日:1989-07-07
Applicant: HOECHST AG
Inventor: KLOSA JOSEF , JOSEF KLOSA , KROEGER HANS , HANS KROEGER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHRINNER ELMAR , ELMAR SCHRINNER
IPC: A61K31/52 , A61P31/12 , C07D473/38 , C07D
-
公开(公告)号:ZA9102015B
公开(公告)日:1991-12-24
申请号:ZA9102015
申请日:1991-03-19
Applicant: HOECHST AG
Inventor: JAEHNE GERHARD , GERHARD JAEHNE , ROESNER MANFRED , MANFRED ROESNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHOLL THOMAS , THOMAS SCHOLL
IPC: A61K31/52 , A61K31/522 , A61P31/12 , A61P31/22 , C07D473/00 , C07D473/04 , C07D473/16 , C07D473/18 , C07D473/20 , C07D473/22 , C07D473/24 , C07D473/28 , C07D473/32 , C07D473/34 , C07D473/36 , C07D473/40 , C07D , A61K
CPC classification number: C07D473/04 , C07D473/16 , C07D473/18 , C07D473/24 , C07D473/32 , C07D473/40
-
公开(公告)号:ZA9010269B
公开(公告)日:1991-09-25
申请号:ZA9010269
申请日:1990-12-20
Applicant: HOECHST AG
Inventor: PEYMAN ANUSCHIRWAN , ANUSCHIRWAN PEYMAN , UHLMANN EUGEN , EUGEN UHLMANN , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: A61K31/66 , A61K31/662 , A61K31/675 , A61K31/685 , A61P31/12 , A61P31/18 , C07F9/38 , C07F9/40 , C07F9/58 , C07F9/653 , C07F9/6539 , C07F9/6558 , C07F9/6571 , C07F , A61K
Abstract: The compound of the formula I in which R represents an aldehyde group or a group which can be converted into an aldehyde, R and R represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, hydrogen, sodium, potassium, calcium, magnesium, aluminium, lithium, ammonium or triethylammonium or R and R together form a cyclic diester, R and R represent alkyl, alkenyl, alkynyl, cycloalkyl, hydrogen, alkoxy or halogen, R and R represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, alkoxy, phenyl, cyanide, hydroxyl or hydrogen, X, Y or Z represent oxygen or sulphur, or prodrug forms of the compound of the formula I can be used for treatment of diseases caused by viruses. The preparation of these compounds and pharmaceutical preparations which contain them and also their use are described.
-
公开(公告)号:ZA8806675B
公开(公告)日:1989-04-26
申请号:ZA8806675
申请日:1988-09-08
Applicant: HOECHST AG
Inventor: WINKELMANN ERHARDT , ERHARDT WINKELMANN , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: C07D473/24 , A61K31/52 , A61P31/12 , C07D473/38 , A61K
CPC classification number: A61K31/52
-
公开(公告)号:AU3191093A
公开(公告)日:1993-07-29
申请号:AU3191093
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: EUGEN UHLMANN , ANUSCHIRWAN PEYMAN , GERARD O'MALLEY , MATTHIAS HELSBERG , IRVIN WINKLER
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/22 , C07F9/24 , C07H1/00 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: The invention relates to compounds of the formula I in which R is H, alkyl, acyl, aryl or a phosphate residue; R is H, OH, alkoxy, NH2 or halogen; B is a base customary in nucleotide chemistry; a is O or CH2; n is an integer from 1 to 100; W is O, S or Se; V is O, S or NH; Y is O, S, NH or CH2; Y' is O, S, NH or alkylene; X is OH or SH; U is OH, SH, SeH, alkyl, aryl or amine, and Z is OH, SH, SeH, an optionally substituted radical from the series comprising alkyl, aryl, heteroaryl, alkoxy or amino or a group which favours intracellular uptake or as labelling of a DNA probe or which on hybridisation interacts with the target nucleic acid, where if Z is OH, SH, CH3 or OC2H5, at least one of the groups X, Y, Y', V, W is not equal to OH or O, or R is not equal to H; process for their preparation and their use as inhibitors of gene expression, as probes for detecting nucleic acids and as aids in molecular biology.
-
公开(公告)号:ZA8900189B
公开(公告)日:1989-09-27
申请号:ZA8900189
申请日:1989-01-10
Applicant: HOECHST AG
Inventor: ZEECK AXEL , AXEL ZEECK , STEINHOFF ILSEMARIE , ILSEMARIE STEINHOFF , HAMMANN PETER , PETER HAMMANN , GRABLEY SUSANNE , SUSANNE GRABLEY , VOELSKOW HARTMUT , HARTMUT VOELSKOW , WINKLER IRVIN , IRVIN WINKLER , SEIBERT GERHARD , GERHARD SEIBERT
IPC: A61K20060101 , C07D20060101 , C07D , A61K
-
公开(公告)号:ZA886676B
公开(公告)日:1989-04-26
申请号:ZA886676
申请日:1988-09-08
Applicant: HOECHST AG
Inventor: WINKELMANN ERHARDT , ERHARDT WINKELMANN , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: A61K31/52 , A61K31/70 , A61K31/7042 , A61K31/7052 , A61K31/7076 , A61K31/715 , A61P31/12 , A61P35/00 , A61P37/04 , C07D473/38 , C07H19/16 , C07D , C07H , A61K
Abstract: Medicines based on compounds of the formula I in which R is H, NH2 or acylamino, and R is a defined organic radical, are particularly suitable for controlling diseases caused by (DNA and RNA) viruses and for the treatment of autoimmune diseases and of cancer.
-
公开(公告)号:ZA885577B
公开(公告)日:1989-04-26
申请号:ZA885577
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SCHRINNER ELMAR , ELMAR SCHRINNER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K , C08B , C07D
Abstract: The preparation contains or consists of… a) at least one sulphated polysaccharide and… b) at least one xanthine derivative. The preparation is suitable for the control and prophylaxis of viral diseases, especially those caused by retroviruses.
-
公开(公告)号:MA22839A1
公开(公告)日:1993-10-01
申请号:MA23133
申请日:1993-03-23
Applicant: HOECHST AG
Inventor: GERHARD JAHNE , IRVIN WINKLER , MATTHIAS HELSBERG , GERHARD GROSS , THOMAS SCHOLL
IPC: A61K31/52 , A61P31/12 , C07D473/00 , C07D473/32
-
10.
公开(公告)号:AU3191193A
公开(公告)日:1993-07-29
申请号:AU3191193
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: EUGEN UHLMANN , ANUSCHIRWAN PEYMAN , GERARD O'MALLEY , MATTHIAS HELSBERG , IRVIN WINKLER
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/24 , C07F9/44 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R = H, a substituent or -P(=W)ZZ'; R = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R , R = substituents; p = 1-100; q = 0-18; R = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta or a group of formula (ii); alpha = 1-11; beta = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha or beta configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR R ); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R , R = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
-
-
-
-
-
-
-
-
-